Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopregnanolone for Traumatic Brain Injury
NCT01673828Phase 2Completed
- Start
- Apr 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brexanolone in traumatic brain injury (TBI). Started Apr 2013; status: completed.
02
Drugs
brexanolone
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT01673828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01673828.